Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Gamma Medica-Ideas

Request full access

Gamma Medica-Ideas develops novel technologies for markets that improve patient health through the early diagnosis of diseases

Los Angeles, United StatesFounded 2000Biotechnology

About Gamma Medica-Ideas

Gamma Medica-Ideas (GMI) operates in the medical technology sector, focusing on the development and manufacturing of advanced diagnostic imaging systems. The company was formed in June 2005 through the merger of Gamma Medica, based in Northridge, California, and Ideas ASA of Oslo, Norway. The integration of these two entities combined Gamma Medica's expertise in imaging systems with Ideas ASA's specialization in imaging detector subsystems. Bradley E. Patt, Ph.D., who was the CEO of Gamma Medica, became the president and CEO of the newly formed company. Thomas Langaard, the former general manager of Ideas, assumed the role of chief operating officer.

The company's business model revolves around designing, developing, and manufacturing next-generation imaging systems for diagnostic medicine, medical research, and safety applications. GMI's revenue is generated through the sale of these systems and by providing related services. Its client base includes medical researchers, pharmaceutical companies, hospitals, and diagnostic clinics. For instance, its pre-clinical systems are utilized by researchers to accelerate studies on disease progression and therapy effectiveness. The company established a global distribution network, with partners like GE Healthcare and SII NanoTechnology in Japan handling its pre-clinical products.

Gamma Medica-Ideas' product portfolio includes the LumaGEM® Molecular Breast Imaging (MBI) system and the FLEX Triumph™ pre-clinical imaging platform. The LumaGEM® system is designed for the early diagnosis of breast cancer, particularly in women with dense breast tissue, a demographic where traditional mammography can be less effective. This system utilizes dual-head Digital Direct Conversion Gamma Imaging™ (DDCGI™) technology with solid-state Cadmium Zinc Telluride (CZT) detectors to provide high-resolution images capable of identifying very small lesions. The FLEX Triumph™ is a versatile pre-clinical platform that can be configured with PET, SPECT, and CT subsystems, making it a tri-modality system. This modularity allows researchers to combine different imaging techniques in a single instrument for comprehensive studies. The company also had a history of adapting technology from other high-tech fields, such as space exploration, for medical and industrial applications.

Source: Dealroom company data

At a glance

Status
Closed
Employees
8
Open positions
None listed

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Oct 2009 $14M $56M Psilos Group · Capital Resource Partners —
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Gamma Medica-Ideas website traffic

Latest recorded traffic for Gamma Medica-Ideas is 70 monthly website visits.

Latest monthly visits70
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Gamma Medica-Ideas in the Los Angeles ecosystem

Live from Dealroom

The Gamma Medica-Ideas office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • Psilos Group
  • Capital Resource Partners
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Los Angeles HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Gamma Medica-Ideas on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Gamma Medica-Ideas’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.